中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2013年
1期
51-53
,共3页
李传玉%巨长桥%李莲娣%周峰
李傳玉%巨長橋%李蓮娣%週峰
리전옥%거장교%리련제%주봉
妊高症%剖宫产%硬膜外麻醉%腰-硬联合麻醉
妊高癥%剖宮產%硬膜外痳醉%腰-硬聯閤痳醉
임고증%부궁산%경막외마취%요-경연합마취
Pregnancy induced hypertension syndrome%Cesarean section%Epidural anesthesia%Combined spinal-epidural anesthesia
目的探讨妊高症剖宫产麻醉配合体会经验.方法对2009年4月~2012年3月在牡丹江医学院附属二院妇产科住院的31例妊高症剖宫产产妇资料进行回顾性分析.结果31例患者中,18例行腰-硬联合麻醉,13例行硬膜外麻醉,入ICU率及住院天数,腰硬联合麻醉组明显低于硬膜外麻醉组;新生儿1~5min Apgar评分≤7分的百分率,腰硬联合麻醉组明显低于硬膜外麻醉组,两组患者的术后血压、胎儿娩出时间、术后并发症均无显著性差异.结论腰-硬联合麻醉运用于妊高症剖宫产是疗效确切并且安全的.
目的探討妊高癥剖宮產痳醉配閤體會經驗.方法對2009年4月~2012年3月在牡丹江醫學院附屬二院婦產科住院的31例妊高癥剖宮產產婦資料進行迴顧性分析.結果31例患者中,18例行腰-硬聯閤痳醉,13例行硬膜外痳醉,入ICU率及住院天數,腰硬聯閤痳醉組明顯低于硬膜外痳醉組;新生兒1~5min Apgar評分≤7分的百分率,腰硬聯閤痳醉組明顯低于硬膜外痳醉組,兩組患者的術後血壓、胎兒娩齣時間、術後併髮癥均無顯著性差異.結論腰-硬聯閤痳醉運用于妊高癥剖宮產是療效確切併且安全的.
목적탐토임고증부궁산마취배합체회경험.방법대2009년4월~2012년3월재모단강의학원부속이원부산과주원적31례임고증부궁산산부자료진행회고성분석.결과31례환자중,18례행요-경연합마취,13례행경막외마취,입ICU솔급주원천수,요경연합마취조명현저우경막외마취조;신생인1~5min Apgar평분≤7분적백분솔,요경연합마취조명현저우경막외마취조,량조환자적술후혈압、태인면출시간、술후병발증균무현저성차이.결론요-경연합마취운용우임고증부궁산시료효학절병차안전적.
Objective To investigate the combined with experience in cesarean section anesthesia of Pregnancy Induced Hypertension Syndrome. Methods Retrospectively analyzing the datas of 31 cases with pregnancy-induced hypertension syndrome who underwent cesarean section in my hospital Obstetrics from 2009 April to 2012 March. Results Study groups included 13 patients receiving epidural anesthesia (EA), 18 patients receiving combined spinal-epidural anesthesia (CSEA). The ratio of entering ICU and Length of stay after cesarean section in group CSEA Was significantly lower than in group EA . The incidence of Apgar scores lower than 7 at 1 min and at 5 min, Were lower in group EA than in group CSEA.There was no significant difference between group CSEA and group EA for postoperative blood pressure, fetal childbirth time, postoperative complications. Conclusion CSEA applied in cesarean section of Pregnancy Induced Hypertension Syndrome is the curative effect and safety.